Refine Search
(45)
(214)
(349)
(369)

Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016’, provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Neurofibromatoses - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neurofibromatoses - Pipeline Review, H2 2016’, provides an overview of the Neurofibromatoses pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neurofibro...

Gaucher Disease Type III - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gaucher Disease Type III - Pipeline Review, H2 2016’, provides an overview of the Gaucher Disease Type III pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016’, provides an overview of the Charcot-Marie-Tooth Disease Type I A pipeline landscape.

The report provides comprehensive information on the therape...

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2017

  • $2,000
  • August 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2017’, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) pipeline landscape.

The report provides comprehensive information ...

Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017

  • $2,000
  • August 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017’, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline landscape.

The report provides comprehensive information ...

Crigler-Najjar Syndrome - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crigler-Najjar Syndrome - Pipeline Review, H1 2018’, provides an overview of the Crigler-Najjar Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017

  • $2,000
  • June 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017’, provides an overview of the Opioid-Induced Bowel Dysfunction (OBD or OIBD) pipeline landscape.

The report provides comprehensive inform...

Barth Syndrome - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Barth Syndrome - Pipeline Review, H2 2018’, provides an overview of the Barth Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Barth Syndrome, ...

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2018’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

The report provides comprehensive information on the...

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2018’, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Down Syndrome - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Down Syndrome - Pipeline Review, H2 2018’, provides an overview of the Down Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Down Syndrome, com...

Prader-Willi Syndrome (PWS) - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) - Pipeline Review, H2 2018’, provides an overview of the Prader-Willi Syndrome (PWS) pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Gaucher Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gaucher Disease - Pipeline Review, H1 2018’, provides an overview of the Gaucher Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gaucher Diseas...

Usher Syndrome - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Usher Syndrome - Pipeline Review, H1 2018’, provides an overview of the Usher Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Usher Syndrome, ...